In China the drug is used in injected-form, but Novo Nordisk is starting to introduce it in tablet form in other countries
the patients who provided their tissue for research
Drug companies are cashing in while they can Novo Nordisk, the Danish creator of Ozempic and Wegovy, made $4.8 billion from the drugs in the third quarter of 2023 alone, boosting the economy in Denmark and leading to lower interest rates for ordinary Danes
The government will also expand coverage for GLP-1s under the deal, officials said, to overweight patients with prediabetes or heart problems, obese patients with comorbidities and severely obese patients, accounting for 10 percent of Medicare patients
Rev Physiol Biochem Pharmacol 175:71102 Lyu H, Wang H, Li L et al (2020) Hepatocyte-specific deficiency of Nrf2 exacerbates carbon tetrachloride-induced liver fibrosis via aggravated hepatocyte injury and subsequent inflammatory and fibrogenic responses